Categories
Tags
Authors: Gupta AK, Venkataraman M, Talukder M, Bamimore MA PMID: 34291720 DOI: 10.1080/09546634.2021.1959506 Abstract Background and objectives: Finasteride 1 mg/day is indicated for androgen-dependent conditions such as male androgenetic alopecia (AGA). Methods: The literature is comprehensively summarized on the pharmacodynamics, pharmacokinetics, mechanism of action, and metabolism of finasteride. Pairwise and network meta-analyses were performed to [...]
Categories: I-RECOVER Post-Vaccine
Tags: Finasteride
Authors: Zarehoseinzade E, Allami A, Ahmadi M, Bijani B PMID: 34169042 PMCID: PMC8214036 DOI: 10.47176/mjiri.35.30 Abstract Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate [...]
Categories: I-CARE Early Covid, MATH+
Tags: COVID-19, Finasteride
Authors: Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L et al. PMID: 19922895 DOI: 10.1016/j.clinthera.2009.09.015 Abstract Background: Finasteride, an inhibitor of the steroid 5alpha-reductase, has been approved for the treatment of benign prostatic hyperplasia and androgenetic alopecia. An orally disintegrating tablet (ODT) 5-mg formulation of finasteride was recently developed. Information regarding [...]
Categories: MATH+
Tags: Finasteride